Alzheimers disease is common, costly, and often mixed with other brain pathology The Alzheimers Association estimates that 7.4 million Americans age 65 and older are living with Alzheimers dementia in 2026
These drugs are going mainstream, and consumers who can afford them are using them for off-label weight loss
However, we provide supporting evidence that the weight loss from semaglutide 2.4 mg can be predominantly attributed to loss of fat mass, as opposed to soft lean tissue mass
Some intranasal sprays (different formulations from those being used in studies) are sold as well
TrumpRx GLP-1 pricingupdate: In November 2025, negotiated pricing through TrumpRx brought Ozempic, Wegovy, Mounjaro, and Zepbound to $245/month less than half of prior cash prices